NasdaqGS:ROIVBiotechs
Roivant Sciences (ROIV) Announces US$500 Million Share Repurchase Program Amid Recent Challenges
Roivant Sciences (ROIV) recently announced significant changes, notably the company's decision to initiate a $500 million share repurchase program, completing the repurchase of 148 million shares since April 2024. This strategic move was announced during a period marked by notable financial challenges, as seen in their earnings report for the quarter ended June 2025, which showed a steep decline in sales and a considerable net loss. Despite these challenges, the company's share price saw a...